Task: Answer the multiple-choice question.
Query: Which compound has a -16.582% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, d, or e without using any other words.
Options:
a Cc1cccc(NC2=NCC(=O)N2Cc2ccccc2)c1
b O=c1cc(O)c2ccc(O)cc2o1
c CC1CCc2c(sc3ncnc(N4CCOCC4)c23)C1
d Cc1cccc(N2CCN(S(=O)(=O)c3ccc4c(c3)C(C)(C)C(=O)N4C)CC2C)c1
e O=C(NC(=S)N1CCN(Cc2ccccc2)CC1)c1cccnc1
Answer: c. CC1CCc2c(sc3ncnc(N4CCOCC4)c23)C1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC1CCc2c(sc3ncnc(N4CCOCC4)c23)C1
CC1CCc2c(sc3ncnc(N4CCOCC4)c23)C1
4-(7-methyl-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidin-4-yl)morpholine